Ma Le-Le, Liu Hui-Min, Luo Chuan-Hong, He Ya-Nan, Wang Fang, Huang Hao-Zhou, Han Li, Yang Ming, Xu Run-Chun, Zhang Ding-Kun
State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine, Chengdu, PR China.
State key Laboratory of Innovation Medicine and High Efficiency and Energy Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang, PR China.
Front Pharmacol. 2021 Mar 22;12:583279. doi: 10.3389/fphar.2021.583279. eCollection 2021.
The coronavirus disease, 2019 (COVID-19), has spread rapidly around the world and become a major public health problem facing the world. Traditional Chinese medicine (TCM) has been fully committed to treat COVID-19 in China. It improved the clinical symptoms of patients and reduced the mortality rate. In light of the fever was identified as one of leading clinical features of COVID-19, this paper will first analyze the material basis of fever, including pyrogenic cytokines and a variety of the mediators of fever. Then the humoral and neural pathways of fever signal transmission will be described. The scattered evidences about fever recorded in recent years are connected in series. On this basis, the understanding of fever is further deepened from the aspects of pathology and physiology. Finally, combining with the chemical composition and pharmacological action of available TCM, we analyzed the mechanisms of TCMs to play the antipyretic effect through multiple ways. So as to further provide the basis for the research of antipyretic compound preparations of TCMs and explore the potential medicines for the prevention and treatment of COVID-19.
2019年冠状病毒病(COVID-19)已在全球迅速传播,成为全球面临的重大公共卫生问题。在中国,中医药已全力投入到COVID-19的治疗中。它改善了患者的临床症状,降低了死亡率。鉴于发热被确定为COVID-19的主要临床特征之一,本文将首先分析发热的物质基础,包括致热细胞因子和多种发热介质。然后将描述发热信号传递的体液和神经途径。将近年来记录的关于发热的零散证据串联起来。在此基础上,从病理和生理方面进一步深化对发热的认识。最后,结合现有中药的化学成分和药理作用,分析了中药通过多种途径发挥解热作用的机制。从而进一步为中药解热复方制剂的研究提供依据,探索预防和治疗COVID-19的潜在药物。